EMA EMA backs 12 new medicines, alongside key label expansions The EMA’s CHMP recommended 12 new medicines for approval and 11 indication extensions at its September 2026 meeting
EMA EMA recommends three new medicines and an orphan treatment for rare Rett Syndrome EMA’s human medicines committee (CHMP) recommended six medicines for approval at its June 2026 meeting
EMA EMA recommends five new medicines addressing rare diseases and aggressive cancers The European Medicines Agency recommends five new therapies, including breakthrough treatments for small cell lung cancer and rare immune disorders, marking progress in areas of high unmet medical need
